exactly what dumb longs are missing. there will be at least a 10% discount to any bid price due to regulatory risk, share price risk of the acquirer (as it will not be all cash) and time value.
market also missing fact that likely to be merger of equals so premium cannot be massive. i can't see a bid above $200. $215 max, which means this will trade sub $200 on deal news.
look at PRGO... deal value of $225, trades at $193
been there and even got email from lady in investor relations.
also company sent email to staff which very much sounded like this rumour was an unnecessary distraction and that this the press speculation was unfortunate.
does not sound like a company looking to sell
all the analysts upgrading targets today have done no research and only been taken in by what will prove to be a false report.
last week worth $160 noe $220-230?? lol
even a $230 cash bid would be discounted to $210 for time (see 5% haircut given to Altera), let alone regulatory risk. cash and stock will be discounted even more.
it's crazy to buy here.
this will be sub-$200 on any news of a bid. if there is one at all.
david faber reported today that nothing is imminent, if at all.
sound of crickets mate. accept that.
if you are genuinely long, why are you not taking $216 when friday it was $175??
the analyst who raised his target has not don eit on the back of research. last friday in his head it was worth $160... today $230???
thats asking for 60/70% premium considering there will be regulatory and time risk.... who pays that??
the company has said nothing about working with GS...
Please provide link to the companies press release.
Always the best time to defraud retail into buying.... all those dummies expected a Monday announcement, and instead you get the sound of crickets.
if there was any merit to this rumour, there would have been additional insider reports on it, just like there has been with Intel and Altera.
Stock goes back to $190 minimum.
stupid greedy friday buyers just get carried away. bunch of dummies.
this should be $60 at least
why is it ridiculous? it's a $6.5bn valuation with a test molecule.... nothing proven. why is $5bn not too expensive, let alone $1bn
it's you who is being stupid.... you have just been told it's 3 years before data!!
and a real possibility of fundraising....and you want it to be valued at $6.5bn plus????
and this trial is longer and more expensive... it's so obvious a sell it's ridiculous. will see the air come out of this
this is crazzzzy..... will go back to $200 so quickly
very rare to be able to buy top notch company.